Abstract | O-GlcNAcylation -the attachment of O-linked N-acetylglucosamine (O-GlcNAc) moieties to cytoplasmic, nuclear and mitochondrial proteins -is a post-translational modification that regulates fundamental cellular processes in metazoans. A single pair of enzymes -O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) -controls the dynamic cycling of this protein modification in a nutrient-and stress-responsive manner. Recent years have seen remarkable advances in our understanding of O-GlcNAcylation at levels that range from structural and molecular biology to cell signalling and gene regulation to physiology and disease. New mechanisms and functions of O-GlcNAcylation that are emerging from these recent developments enable us to begin constructing a unified conceptual framework through which the significance of this modification in cellular and organismal physiology can be understood.
The post-translational modification (PTM) of proteins enables cells to respond promptly to internal and external cues through direct and dynamic control of protein function. Owing to a greater appreciation for their essential roles in regulating diverse cellular processes, PTMs such as phosphorylation, acetylation, and ubiquityl ation have garnered considerable interest over the past few decades. However, beyond these well-studied modifications are many others whose significance in normal and disease physiology is only beginning to be understood. Notable among these emerging PTMs, O-GlcNAcylation is a non-canonical glycosylation that involves the attachment of single O-linked N-acetylglucosamine (O-GlcNAc) moieties to Ser and Thr residues of cytoplasmic, nuclear and mitochondrial proteins 1, 2 . O-GlcNAcylation is the product of nutrient flux through the hexosamine biosynthetic pathway (HBP), which integrates glucose, amino acid, fatty acid and nucleotide metabolism to generate the donor substrate for O-GlcNAcylation, uridine diphosphate GlcNAc (UDP-GlcNAc) (FIG. 1a) . In addition to being dependent on nutrient availability, O-GlcNAc signalling is highly sensitive to various forms of cellular stress (for example, heat shock, hypoxia and nutrient deprivation), although the mechanisms mediating this response are only beginning to be described 2 . As a result, O-GlcNAcylation has been proposed to function as a nutrient and stress sensor that regulates cellular processes that range from transcription and translation to signal transduction and metabolism 1, 2 . Physiologically, disruption of O-GlcNAc homeostasis has been implicated in the pathogenesis of many human diseases, which include cancer, diabetes and neurodegeneration [3] [4] [5] [6] [7] [8] [9] .
There is a large body of evidence indicating that O-GlcNAcylation engages in a complex interplay with other PTMs
. However, whereas other PTMs are often regulated by a diverse array of 'writers' and ' erasers' , O-GlcNAcylation is controlled by a single pair of enzymes: O-GlcNAc transferase (OGT), which cataly ses the transfer of a GlcNAc moiety from the donor substrate UDP-GlcNAc to the hydroxyl groups of target Ser and Thr residues; and O-GlcNAcase (OGA), which catalyses the hydrolysis of this sugar modification 1, 2 (FIG. 1a). Owing to alternative splicing and alternate start codons, multiple isoforms of OGT and OGA can be gener ated from the OGT and meningioma expressed antigen 5 (MGEA5) genes, respectively (FIG. 1b) . The three isoforms of OGT (nucleocytoplasmic (ncOGT), mitochondrial (mOGT) and short (sOGT)) share common carboxy-terminal catalytic and phosphoinositidebinding domains, but they differ in length owing to variable numbers of amino-terminal tetratricopeptide repeats (TPRs). These isoforms also differ in subcellular localization: ncOGT and sOGT are present in the cytoplasm and nucleus, whereas mOGT is found in the mitochondria. There are two isoforms of OGA: a nucleocytoplasmic isoform (ncOGA), which possesses both an N-terminal O-GlcNAc hydrolase domain and a C-terminal histone acetyltransferase-like (HAT-like) domain; and a short isoform (sOGA), which lacks the HAT-like domain and is localized to the endoplasmic reticulum and lipid droplets 6, 10 .
Remarkable advances in our understanding of the biochemistry, molecular and cell biology, and physiology of O-GlcNAcylation have been made over the past decade. With growing interest in O-GlcNAcylation and the development of improved genetic and pharmacological tools to study its function, we expect that our understanding of this modification will continue to increase exponentially over the next several years.
Thus, in this Review, we explore major scientific questions in the field and thereby provide a conceptual framework that will guide future studies in this area. Here, we consider potential mechanisms that enable the recognition of hundreds of protein substrates by a single pair of enzymes (OGT and OGA), discuss how O-GlcNAcylation regulates cellular processes temporally and spatially in response to nutritional and hormonal cues, and explore how O-GlcNAc homeostasis may be maintained in order to achieve optimal cellular function. As there are already many comprehensive reviews that describe the diverse functions of O-GlcNAcylation, the focus of this Review is to consolidate this knowledge into unifying concepts, placing an emphasis on contextualizing the significant advances that have occurred in the field over the past several years 1, 2, 4, 6, [10] [11] [12] .
Substrate recognition by OGT and OGA How a single pair of enzymes (OGT and OGA) is able to recognize hundreds of protein substrates has been a long-standing question in the field. Whereas attempts to identify strict consensus sequences that control substrate recognition have been unsuccessful, biochemical, biophysical and computational analyses of the molecular structures of OGT and OGA have revealed potential mechanisms that together may confer substrate specificity to these enzymes.
Structural features and isoforms of OGT.
The crystal structure of human OGT in a ternary complex with UDP and a peptide substrate shows that peptides are anchored in the OGT active site primarily by OGT sidechain contacts with the peptide amide backbone 13 . The relative importance of active site contacts with the peptide backbone versus those with the peptide side chains reinforces the notion that OGT lacks a strict consensus sequence for substrate recognition. However, OGT has been shown to preferentially modify Ser and Thr residues that are flanked by amino acids that enforce an extended peptide conformation (for example, prolines and β-branched amino acids), which suggests that moderate sequence constraints that are imposed by the active site may have some influence on OGT substrate selection 13, 14 .
In the absence of a strict consensus sequence, OGT may achieve some level of substrate specificity through structural motifs outside of the active site. Indeed, the prevailing view in the field is that OGT substrate recognition is mediated by the N-terminal TPR domain, an extended superhelical structure composed of up to 13.5 TPRs that is thought to function as a scaffold for the assembly of protein complexes 15 . Individually or in combination, these TPRs could facilitate substrate recognition by generating unique binding sites that, when occupied, induce a conformational change that permits the substrate to access the active site (FIG. 2a) . This model is supported by biochemical studies that demonstrate that specific TPRs are required for the interaction of OGT with individual substrates such as SIN3A and teneleven translocation 2 (TET2) [16] [17] [18] [19] . Furthermore, structural analyses and molecular dynamics simulations suggest Whereas the majority of glucose is used for glycolysis and glycogen synthesis, approximately 2-5% of glucose is channelled into the hexosamine biosynthetic pathway (HBP). Glutamine-fructose-6-phosphate amidotransferase 1 (GFAT1) catalyses the rate-limiting step of the HBP, which converts fructose-6-phosphate (Fru-6P) into glucosamine-6-phosphate (GlcN-6P). Subsequent acetylation of GlcN-6P (to yield N-acetylglucosamine-6-phosphate (GlcNAc-6P)) and uridylation of GlcN-1P yields the donor substrate for protein O-GlcNAcylation (the attachment of O-linked N-acetylglucosamine (O-GlcNAc) moieties to Ser and Thr residues of intracellular proteins), uridine diphosphate GlcNAc (UDP-GlcNAc). O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) catalyse the addition and removal of O-GlcNAc, respectively. Free GlcNAc can be recycled via the GlcNAc salvage pathway, which converts GlcNAc into GlcNAc-6P that can be utilized by the HBP. b | Schematic representation of the OGT and OGA isoforms. The nucleocytoplasmic (ncOGT), mitochondrial (mOGT) and short (sOGT) isoforms of OGT differ in length owing to variable numbers of amino-terminal tetratricopeptide repeats (TPRs) but share common carboxy-terminal catalytic (CDI and II) and phosphoinositide-binding (PPO) domains. mOGT contains a unique N-terminal mitochondrial targeting sequence (MTS). The nucleocytoplasmic (ncOGA) and short (sOGA) isoforms of OGA possess identical N-terminal O-GlcNAc hydrolase domains and central OGT-binding regions; however, sOGA lacks the C-terminal histone acetyltransferase-like (HAT-like) domain that is present in ncOGA.
Molecular dynamics simulations
A computational method that simulates the physical movements of atoms and molecules; it can be used to model the internal motions and conformational changes of biological macromolecules to understand the physical basis of their structures and functions.
Orexin
A hypothalamic neuropeptide that regulates appetite, arousal and wakefulness; it is also known as hypocretin.
that the TPR domain can shift from obscuring to fully exposing the active site by pivoting around a 'hinge' region between the TPR and catalytic domains 13 . Thus, the TPR domain may confer substrate specificity by acting as a 'gatekeeper' that restricts access to the active site until a potential substrate occupies its unique binding site that is formed by specific TPRs.
The crystal structure of OGT in a complex with UDP and an OGT-binding peptide derived from host cell factor C1 (HCF1) provides insight into how the TPR domain may form binding sites for OGT substrates. Specifically, the Thr-rich HCF1 peptide occupies a channel that is generated by the TPR domain in which conserved Asn residues engage the peptide backbone and Asp residues form hydrogen bonds with the peptide side chains 20 . This model is consistent with earlier hypotheses that were derived from structural analysis of the TPR domain alone, which proposed that conserved Asn residues within the TPR motifs define binding pockets that in tandem may facilitate substrate recognition. Intriguingly, the TPR domain of OGT was noted to have structural similarities to the peptide-binding site of importin-α, which utilizes an analogous mechanism to bind various nuclear localization signals 21 .
As the three isoforms of OGT differ in TPR domain length and in subcellular localization (FIG. 1b) , they may target distinct but overlapping subsets of the proteome 22 . Indeed, tau and the tyrosine kinase YES have been identified as substrates that are unique to ncOGT and mOGT, respectively, whereas proteins such as nucleoporin 62 (NUP62) and casein kinase 2 are O-GlcNAcylated by both isoforms 23 . Thus, some evidence suggests that OGT may also achieve some level of substrate specificity through its different isoforms. However, a recent study reported that endogenous levels of mOGT are extremely low in a number of human cell lines and murine tissues, and that overexpression of ncOGT is sufficient to increase O-GlcNAcylation of mitochondrial proteins 24 . These findings highlight the uncertain role of mOGT in O-GlcNAc signalling and demonstrate the need for an improved understanding of the other OGT isoforms (mOGT and sOGT).
Adaptor protein hypothesis. OGT substrate recognition may also be mediated by adaptor proteins that recruit substrates to OGT in a context-dependent manner. For example, during glucose deprivation, activated p38 mitogen-activated protein kinase (MAPK) interacts with the C terminus of OGT and recruits OGT to the neurofilament heavy polypeptide NFH, which leads to increased O-GlcNAcylation and solubility of NFH 25 . During fasting, HCF1 functions as an adaptor protein that targets OGT to PPARγ co-activator 1α (PGC1α), which enhances the O-GlcNAcylation and stability of PGC1α and thereby upregulates the expression of genes involved in gluconeogenesis 26 . Specifically, OGT, HCF1 and PGC1α were shown to form a complex, and mutation of the HCF1-binding motif of PGC1α abolished O-GlcNAcylation of PGC1α. Unexpectedly, OGA has also been implicated as an OGT adaptor protein: OGT and OGA can interact to form an 'O-GlcNAczyme' complex 27 and, in high glucose conditions, acetylation of pyruvate kinase isoform M2 (PKM2; encoded by PKM) by the HAT-like domain of OGA promotes OGT-PKM2 interaction and O-GlcNAcylation of PKM2, which leads to increased aerobic glycolysis in cancer cells (X.Y. and K.Q., unpublished observations).
As individual proteins (p38 MAPK, HCF1 and OGA) function as adaptors for OGT primarily in certain conditions (glucose deprivation, fasting and high glucose levels), together they may facilitate targeting of OGT to the appropriate substrates (NFH, PGC1α and PKM2) in these specific cellular contexts. Thus, we hypothesize that interaction with a hierarchy of highly conserved adaptor proteins, each responsible for recognizing and recruiting specific substrates, is an additional mech anism that enables OGT to control the O-GlcNAcylation of hundreds of proteins in a context-dependent manner (FIG. 2b) . The well-characterized ubiquitylation system The post-translational modification (PTM) code hypothesis proposes that combinatorial modification of proteins with a variety of PTMs generates a dynamic 'code' that can be translated into complex biological outcomes 116 . This code is edited by 'writers' and 'erasers' (for example, kinases and phosphatases in the case of phosphorylation) and translated through direct modulation of protein function or by 'readers' (for example, phosphotyrosine-binding proteins) that subsequently regulate protein complex formation and signal transduction. As O-GlcNAcylation (the attachment of O-linked N-acetylglucosamine (O-GlcNAc) moieties to Ser and Thr residues of intracellular proteins) is highly sensitive to changes in the cellular environment and interacts extensively with other PTMs, we hypothesize that O-GlcNAcylation plays a unique and essential role in the PTM code. Below, we briefly discuss examples of crosstalk between O-GlcNAcylation and other common PTMs.
Phosphorylation
As phosphorylation can also target Ser and Thr residues, the interaction between O-GlcNAcylation and phosphorylation has been well studied. O-GlcNAcylation has been shown to occur reciprocally or sequentially with phosphorylation on the same or neighbouring residues of numerous proteins 1, 2 .
Ubiquitylation
Several studies have demonstrated that O-GlcNAcylation can block the degradation of target proteins by reducing their ubiquitylation. Potential mechanisms for this inhibition include recruitment of deubiquitylases to O-GlcNAcylated proteins and indirect modulation of ubiquitylation through crosstalk with phosphorylation 26, 38, 39 .
Acetylation O-GlcNAcylation of nuclear factor-κB (NF-κB) potentiates its acetylation by E1A-binding protein p300 (REF. 117 ); conversely, O-GlcNAcase (OGA)-mediated acetylation of pyruvate kinase isoform M2 (PKM2; encoded by PKM) enhances its O-GlcNAcylation (X.Y. and K.Q., unpublished observations). These modifications also have an intrinsic reciprocal relationship due to the fact that OGA possesses both a histone acetyltransferase-like (HAT-like) domain and an O-GlcNAc hydrolase domain. Indeed, in cells that do not express orexin, transcription of hypocretin neuropeptide precursor (Hcrt; encodes prepro-orexin) is repressed by O-GlcNAc transferase (OGT) and the NAD-dependent protein deacetylase sirtuin 1 (SIRT1) through histone O-GlcNAcylation and deacetylation; however, in orexin-expressing neurons, OGA and the histone acetyltransferases p300 and CREB-binding protein (CBP) activate Hcrt transcription via the reverse reactions 118 .
Methylation
Several studies suggest that OGT can regulate transcription in concert with ten-eleven translocation (TET) proteins, which are thought to promote DNA demethylation by hydroxylating 5-methylcytosine (5mC) 18, 19, [74] [75] [76] . Thus, crosstalk between O-GlcNAcylation and DNA methylation may contribute to the regulation of transcription (see discussion in Regulation of epigenetics).
PPARγ co-activator 1α
(PGC1α). A transcriptional co-activator and master regulator of gluconeogenesis and mitochondrial biogenesis.
Gluconeogenesis
A metabolic pathway that produces glucose from various carbon sources that include glycerol, lactate and some amino acids; it occurs primarily in the liver and kidney in mammals.
Pyruvate kinase isoform M2
(PKM2). An isozyme of pyruvate kinase, the enzyme that catalyses the final step of glycolysis; it has been implicated in the reprogramming of metabolic pathways in cancer.
Aerobic glycolysis
The preferential utilization of glycolysis and lactic acid fermentation for ATP production despite the availability of oxygen for oxidative phosphorylation; it is a hallmark of metabolic reprogramming in cancer.
is known to follow a similar paradigm, in which the hundreds of E3 ubiquitin ligases confer substrate specificity to the tens of E2 ubiquitin-conjugating enzymes by acting as adaptor proteins 28 .
Nonspecific O-GlcNAcylation hypothesis. As peptides are anchored in the OGT active site by OGT side-chain contacts with the peptide backbone, OGT has been proposed to O-GlcNAcylate proteins in flexible regions (for example, loops and termini) that can bind to the active site in an extended conformation to expose the amide backbone 13 . Thus, OGT is thought to preferentially modify substrates that contain flexible elements, which is corroborated by studies showing that proteins with regions of intrinsic disorder (for example, nuclear pore proteins, specificity protein 1 (SP1), forkhead box protein O1 (FOXO1) and tau) are heavily O -GlcNAcylated in these disordered regions 8, [29] [30] [31] [32] . These observations raise the intriguing possibility that OGT can nonspecifically modify proteins in unstructured regions without recognizing any specific sequences or structures. In this case, substrate selection would be influenced only by sequence preferences that are intrinsic to the active site owing to size and conformational restrictions 14 . Nature Reviews | Molecular Cell Biology (O-GlcNAc; denoted G) transferase (OGT) may achieve some level of substrate specificity through its amino-terminal tetratricopeptide repeat (TPR) domain. Individually or in combination, TPRs could facilitate substrate recognition by generating unique binding sites that, when occupied, induce a conformational change that permits the substrate to access the active site. TPRs 1-6 are required for OGT binding to SIN3A and TPRs 5-6 are required for OGT binding to ten-eleven translocation 2 (TET2), although TPRs 9-12 may also be involved. b | OGT substrate recognition may also be mediated by a hierarchy of highly conserved adaptor proteins, each responsible for recognizing and recruiting specific substrates to OGT in a context-dependent manner. For example, in each of three different nutrient conditions (glucose deprivation, fasting and high glucose levels), OGT is recruited by a specific adaptor protein (p38, HCF1 and OGA) to O-GlcNAcylate a specific substrate (NFH, PGC1α and PKM2), leading to regulation of key downstream cellular pathways (NFH solubility, gluconeogenic gene expression and aerobic glycolysis). c | Accumulation of unfolded proteins in the endoplasmic reticulum during cellular stress activates the unfolded protein response, which upregulates hexosamine biosynthetic pathway (HBP) gene expression via the transcription factor spliced X box-binding protein 1 (XBP1s). Increased production of UDP-GlcNAc by the HBP may lead to nonspecific O-GlcNAcylation of unfolded proteins in the cytoplasm. O-GlcNAcylation of unfolded proteins may block their aggregation and proteasomal degradation (by inhibiting protein ubiquitylation or proteasomal function) as well as facilitate their refolding by chaperones with O-GlcNAc-directed lectin activity (for example, heat shock protein 70 (HSP70)). CD, catalytic domain; GALE, UDP-galactose-4-epimerase; GFAT1, glutamine-fructose-6-phosphate amidotransferase 1; GNPNAT1, glucosamine-phosphate N-acetyltransferase 1; HCF1, host cell factor C1; NFH, neurofilament heavy polypeptide; OGA, O-GlcNAcase; PGC1α, PPARγ co-activator 1α; PGM3, phosphoglucomutase 3; PKM2, pyruvate kinase isoform M2; PPO, phosphoinositide-binding domain; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine. 
Molecular docking simulations
A computational method that simulates the process of a ligand binding to an enzyme or receptor; it can be used to predict the preferred orientation of a ligand in the active site of an enzyme.
Under normal physiological conditions, nonspecific O-GlcNAcylation is unlikely to be a major mechanism of OGT substrate selection owing to the limited number of flexible elements in most mature proteins. However, during cellular stress, the availability of these elements may increase owing to accumulation of unfolded proteins in the cytoplasm or within cellular compartments. Perhaps not coincidentally, cellular O-GlcNAcylation levels are also dramatically elevated in response to various stress stimuli 33 . Accumulation of unfolded proteins in the cell activates stress response pathways such as the unfolded protein response (UPR) that can combat proteotoxic stress by blocking protein aggregation, modulating protein degradation and facilitating protein refolding 34 . Spliced X box-binding protein 1 (XBP1s), a conserved UPR signal transducer and highly active transcription factor, has been shown to increase cellular O-GlcNAcylation levels through direct upregulation of HBP gene expression 35 (FIG. 2c) . Coupling of the HBP to the UPR suggests that O-GlcNAcylation may have a crucial role in the handling of unfolded proteins during cellular stress. Indeed, accumu lating evidence indicates that O-GlcNAcylation is a key component of the cellular response to perturbations in protein homeostasis. For example, O-GlcNAcylation has been shown to block proteotoxic aggregation of proteins that are associated with neurodegenerative disease, such as tau (Alzheimer disease) and α-synuclein (Parkinson disease), as well as thermal aggregation of unrelated proteins such as TAK1-binding protein 1 (TAB1) 7, 36 . At the same time, O-GlcNAcylation can protect proteins from degradation by inhibiting proteasome function (by direct modification of 26S protease regulatory subunit 4 (P26S4; also known as RPT2) and inhibition of the ATPase activity of the 26S proteasome) or reducing protein ubiquitylation, and it may facilitate protein refolding by recruiting chaperones with O -GlcNAc-directed lectin activity 26, [37] [38] [39] [40] [41] [42] . Taken together, these observations raise the intriguing possibility that, in response to cellular stress, nons pecific O-GlcNAcylation occurs in unstructured regions of unfolded proteins in order to block their aggregation and degradation and facilitate their refolding (FIG. 2c) .
This hypothesis is further supported by a recent study, which demonstrates that O-GlcNAcylation also occurs co-translationally on nascent polypeptides to protect them from premature ubiquitin-mediated degradation. Specifically, nascent SP1 and NUP62 polypeptides, which are likely to be highly unstructured, were found to be more heavily O-GlcNAcylated than their mature counterparts, reinforcing the notion that unfolded proteins are attractive substrates for OGT. Furthermore, the fact that co-translational O-GlcNAcylation regulates protein quality control by reducing nascent polypeptide ubiquitylation is consistent with the notion that O-GlcNAcylation of unfolded proteins plays a crucial role in maintaining protein homeostasis 30 .
Substrate recognition by OGA. Insight into potential mechanisms that govern OGA substrate recognition has been limited by the lack of a crystal structure for a eukaryotic OGA 43 ; however, three reports that describe partial structures of human OGA were recently published [44] [45] [46] and provide insight into the structural basis of substrate recognition by OGA. However, multiple studies have elucidated the structures of bacterial glyco sidases that are close homologues of human OGA, some of which have been shown to possess in vitro O-GlcNAc hydrolase activity towards human proteins 47, 48 . Crystal structures of NagJ from Clostridium perfringens in a complex with various synthetic glycopeptides reveal that NagJ binds to different substrates in similar conformations by interacting primarily with the peptide backbone and sugar moiety and avoiding contact with the peptide side chains 49 . Similar results were obtained from molecular dynamics and molecular docking simulations that analysed models of various O-GlcNAcylated peptides in a complex with Bacteroides thetaiotaomicron glycoside hydrolase 84 (GH84). These findings suggest that OGA substrate recog nition generally lacks sequence sensitivity, although variations in sequence near the O-GlcNAcylation site are predicted to have some effect on OGA-glycopeptide 
Transrepression
The repression of the activity of one protein (for example, a transcription factor) through its interaction with a second protein.
Pre-initiation complex
A large protein assembly that performs various functions that are required for transcription initiation (for example, the recruitment of RNA polymerase II to transcription start sites and the unwinding of DNA to allow for RNA polymerase II binding).
binding affinity 50 . Although structural features and adaptor proteins could also confer substrate specificity to OGA, evidence for these mechanisms is limited at this time. We suspect that intrinsic substrate promiscuity enables OGA to recognize hundreds of O-GlcNAcylated proteins, analogous to how promiscuous protein phosphatases control the removal of phosphorylation that is installed by hundreds of protein kinases.
Functions of O-GlcNAcylation
Traditionally, protein glycosylation is thought to occur only in the endoplasmic reticulum, Golgi apparatus and extracellular matrix. However, O-GlcNAcylation can be found on proteins in the cytoplasmic, nuclear, mitochondrial and plasma membrane compartments, in which it regulates fundamental cellular processes such as transcription, epigenetic modifications and cell signalling dynamics. By engaging in diverse protein complexes in a context-dependent and cellular compartment-specific manner, OGT and OGA can coordin ately regulate complex networks of spatially separated cellular processes.
Regulation of transcription.
Although OGT and OGA are present in both the nucleus and the cytoplasm, OGT is specifically enriched in the nucleus, whereas OGA is predominantly cytosolic [51] [52] [53] . Consistent with a significant nuclear role for OGT, early studies demonstrated that transcription factors are modified by O-GlcNAc, which implicates this modification in transcriptional regulation 54 . As the repertoire of O-GlcNAcylated transcription factors and cofactors has steadily expanded, their biological functions have also become increasingly recognized. For example, in T and B lymphocytes, OGT O-GlcNAcylates the crucial transcription factors nuclear factor of activated T cells cyto plasmic 1 (NFATC1) and nuclear factor-κB (NF-κB) and is required for lymphocyte activation 55 . In hepatocytes, O-GlcNAcylation of CREB-regulated transcription co-activator 2 (CRTC2), FOXO1 and PGC1α modulates the expression of gluconeogenic genes 26, 56, 57 . Ultimately, regulation of cell type-and tissue-specific genetic programmes by O-GlcNAcylation gives rise to its many distinct functions in individual cell types and tissues (TABLE 1) .
Mechanistically, O-GlcNAcylation can affect the translocation, DNA binding, transactivation and stability of transcription factors. In the case of NF-κB, O-GlcNAcylation of the RELA (also known as transcription factor p65) subunit decreases its binding to NF-κB inhibitor-α (IκBα) and increases its nuclear translocation and transcriptional activity, whereas O-GlcNAcylation of c-REL is required for its DNA binding and transactivation 55, 58, 59 . However, the effects of OGT on NF-κB are context-dependent: in the presence of the glucocorticoid receptor (GR), OGT mediates the transrepression of NF-κB activity 60 . SP1 is another prototypical transcription factor that illustrates the role of O-GlcNAcylation in transcriptional regulation. O-GlcNAcylation of SP1 has been shown to modulate its nuclear localization, transactivation and stability [61] [62] [63] (FIG. 3a) .
It has been known for over two decades that RNA polymerase II (Pol II) is modified by O-GlcNAc 64 . The C-terminal domain (CTD) of Pol II is reciprocally O-GlcNAcylated and phosphorylated at Ser2 and Ser5. O-GlcNAcylated Pol II is enriched at transcription start sites and is involved in the assembly of the preinitiation complex, whereas removal of O-GlcNAcylation from the Pol II CTD allows for its dynamic phosphorylation during transcription initiation and elongation 65, 66 ( FIG. 3a) . Thus, it is conceivable that, at actively transcribed genes, the sequential action of OGT and OGA is essential for recycling Pol II back to the pre-initiation complex after a round of transcription. As a result, perturbation of OGT or OGA function would lead to Pol II stalling and a block in the transcription cycle.
Regulation of epigenetic programmes. The discovery that OGT interacts with diverse epigenetic regulators 10, [66] [67] [68] has initiated an exciting area of study that relates to the nuclear functions of O-GlcNAcylation. An early study identified an association between ncOGT and the SIN3A-histone deacetylase (HDAC) corepressor complex and proposed that O-GlcNAcylation of transcription factors and Pol II acts in parallel with histone deacetylation to promote gene silencing 16 . This model has been greatly expanded by recent findings, which demonstrate that OGT interacts with various other proteins that are involved in histone modification and DNA methylation 10, [66] [67] [68] (FIG. 3b) .
HCF1 is an auxiliary protein for a battery of histonemodifying enzymes, which include histone methyltransferases, demethylases, acetyltransferases and HDACs 68 . Approximately 50% of nuclear OGT exists in a complex with HCF1, which links OGT to these various histone modifications 69 . The OGT-HCF1 complex has been shown to interact with BRCA1-associated protein 1 (BAP1), a component of the Polycomb repressive deubiquitylase (PR-DUB) complex that deubiquityl ates histone H2A 26, 70 . OGT is also required for the trimethyl ation of histone H3 on Lys27 (H3K27me3), probably because it stabilizes the histone methyltransferase enhancer of zeste homologue 2 (EZH2) and maintains the integrity of Polycomb repressive complex 2 (PRC2) 71, 72 . Thus, nuclear OGT may regu late epigenetic programmes by modulating histone acetylation, ubiquityl ation and methylation (FIG. 3b) . However, the epistatic relationships between OGT and histone-modifying enzymes are largely unclear.
DNA methylation at the 5-carbon position of cytosine (5mC) is a key epigenetic mark. The reversal of DNA methylation is mediated by TET proteins that successively oxidize 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5f C), and 5-carboxylcytosine (5caC) 73 . Recent studies have revealed that a large percentage of nuclear OGT exists in a complex with TET proteins [66] [67] [68] . Some studies suggest that TET proteins facilitate the recruitment of OGT to chromatin to enhance histone O-GlcNAcylation, whereas others suggest that OGT can directly O-GlcNAcylate TET proteins and modulate their stability or nuclear localization 18, 19, 74, 75 . Furthermore, OGT and TET proteins may act cooperatively to maintain the integrity and activity of the complex proteins associated with Set1 (COMPASS) H3K4 methyltransferase complex 76 . Although the functional relationship between OGT and TET proteins is still controversial, these studies highlight an important link between OGT and DNA methylation in epigenetic regulation.
Temporal regulation of cell signalling dynamics.
O-GlcNAcylation is a key regulator of the temporal dynamics of various cell signalling pathways. The most well-studied example of this phenomenon is the temporal regulation of insulin signalling dynamics by O-GlcNA cylation 77 . An early study showed that global elevation of O-GlcNAcylation levels in cultured adipocytes using the non-selective OGA inhibitor PUGNAc Pol II) regulates transcriptional activation and repression. On the one hand, O-GlcNAcylation of nuclear factor-κB (NF-κB) promotes its nuclear translocation (by blocking its interaction with NF-κB inhibitor-α (IκBα)) and enhances its DNA-binding and transcriptional activity. On the other hand, the glucocorticoid receptor (GR) can directly bind to NF-κB and recruit O-GlcNAc transferase (OGT) to repress NF-κB activity. O-GlcNAcylation of specificity protein 1 (SP1) increases its nuclear localization and its stability but at the same time inhibits its transactivation. O-GlcNAcylation of Pol II on its carboxy-terminal domain (CTD) is important for the assembly of pre-initiation complexes at transcription start sites, whereas removal of O-GlcNAcylation from the Pol II CTD allows for its dynamic phosphorylation (P) during transcription initiation and elongation. Thus, reciprocal O-GlcNAcylation and phosphorylation of the Pol II CTD is essential for the maintenance of an unperturbed transcription cycle. b | OGT has various roles in epigenetic regulation. The OGT-host cell factor C1 (HCF1) complex binds to ten-eleven translocation (TET) proteins, which catalyse cytosine 5-hydroxymethylation of genomic DNA and thereby promote DNA demethylation. OGT-HCF1 also binds to BRCA1-associated protein 1 (BAP1), which mediates deubiquitylation of histone H2A. OGT also stabilizes enhancer of zeste homologue 2 (EZH2), a component of Polycomb repressive complex 2 (PRC2), to promote histone H3 Lys27 trimethylation. Furthermore, OGT acts in concert with the SIN3A-histone deacetylase (HDAC) co-repressor complex to silence gene expression by promoting histone deacetylation. OGT may also directly O-GlcNAcylate histones through unknown mechanisms (question mark). c | O-GlcNAcylation is involved in the temporal regulation of insulin signalling dynamics. Binding of insulin to the insulin receptor (IR) induces IR autophosphorylation and the subsequent Tyr phosphorylation of insulin receptor substrate 1 (IRS1). Phosphorylated IRS1 binds to and activates phosphoinositide 3-kinase (PI3K), which catalyses the production of phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ). PIP 3 recruits 3-phosphoinositide-dependent protein kinase 1 (PDK1) and AKT to the plasma membrane, which leads to the phosphorylation and activation of AKT and increased glucose uptake and anabolic cellular metabolism. In response to prolonged insulin stimulation, OGT translocates from the nucleus to the cytoplasm and localizes to the plasma membrane by binding to PIP 3 , which leads to Tyr phosphorylation and activation of OGT by IR. OGT then O-GlcNAcylates and inhibits key insulin signalling mediators such as IRS1, PI3K, PDK1 and AKT, blocking their phosphorylation and/or interactions and thereby facilitating the termination of insulin signal transduction. Ac, acetylation; Glc, glucose; GLUT, glucose transporter; Me, methylation; Ub, ubiquitylation; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine. blocks insulin-stimulated phosphorylation of AKT 78 , a Ser/Thr kinase that is crucial for cell survival and metabolism. Conversely, overexpression of OGA in HepG2 hepatoblastoma cells results in decreased AKT O-GlcNAcylation and increased AKT phosphorylation and activity 79 . The O-GlcNAcylation sites in AKT have been mapped to Thr308 and Ser473, which are also crucial phosphorylation sites for AKT activation 80 . These observations suggest that O-GlcNAcylation of AKT directly competes with its phosphorylation.
Phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) is a central mediator of insulin signal transduction. Upon insulin stimulation, phosphoinositide 3-kinase (PI3K) catalyses the production of PIP 3 , which recruits 3-phosphoinositide-dependent kinase 1 (PDK1; also known as PDPK1) and AKT to the plasma membrane, where PDK1 phosphorylates and activates AKT 81 . Interestingly, like PDK1 and AKT, OGT is a PIP 3 -binding protein 5 . After prolonged insulin stimulation, PIP 3 recruits OGT from the cytoplasm to the plasma membrane, where it O-GlcNAcylates and inhibits multiple components of the insulin signalling pathway, which leads to a gradual attenuation of insulin signal transduction 5, 82 (FIG. 3c) . Although a large body of evidence indicates that O-GlcNAcylation negatively regu lates insulin signalling, global elevation of cellular O-GlcNAcylation levels by selective OGA inhibitors such as NButGT and 6-Ac-Cas fails to induce insulin resistance 83 . These seemingly contradictory results can be reconciled if it is assumed that mutual regulation of OGT and OGA is crucial for temporal control of insulin signalling dynamics (see discussion in Maintenance of O-GlcNAc homeostasis).
Temporal regulation of O-GlcNAc signalling.
O-GlcNAcylation is highly dynamic and often occurs transiently in response to diverse environmental and physiological cues, which suggests that O-GlcNAc signalling itself is also under tight temporal control. For example, cellular O-GlcNAcylation levels are globally downregulated in the first few hours following glucose deprivation but are markedly upregulated at later time points 25, 84, 85 . In adipocytes, insulin stimulates robust but transient O-GlcNAcylation of components of the insulin signalling pathway within 30 minutes 5 . In T and B lympho cytes, O-GlcNAcylation of the transcription factor NFATC1 surges 5-10 minutes after lymphocyte activation 55 . Remarkably, O-GlcNAcylation levels in neurons rapidly increase in the 1-2 minutes following depolarization but return to baseline levels within 5 minutes 86 . As the transience of O-GlcNAcylation cannot simply be explained by changes in the intracellular availability of UDP-GlcNAc, unveiling the molecular mechanisms that dynamically regulate O-GlcNAc signalling is one of the most pressing challenges in the field.
To date, little is known about how various stimuli trigger dynamic changes in protein O-GlcNAcylation. Reducing UDP-GlcNAc levels by glucose deprivation has been reported to increase the expression of OGT and decrease the expression of OGA, which points to the existence of a transcriptional feedback loop that helps maintain O-GlcNAc homeostasis 25, 84, 85 (see discussion in Maintenance of O-GlcNAc homeostasis). However, as mentioned above, fluctuations in cellular O-GlcNA cylation levels often occur on the timescale of minutes, which indicates that modulation of gene expression is unlikely to be the primary mode of regulation for the O-GlcNAc signalling pathway. We envision that the PTMs of OGT and OGA are the major regulators of O-GlcNAc signalling dynamics; thus, identifying and characterizing the functions of these putative modifications will provide crucial insight into the temporal regulation of O-GlcNAcylation.
Nutritional and hormonal regulation
At the nexus of glucose, amino acid, fatty acid and nucleo tide metabolism, O-GlcNAcylation is optimally poised to function as a nutrient sensor, coupling fluctuations in nutrient availability to shifts in downstream signalling pathways. The prevailing view in the field has been that cellular O-GlcNAcylation levels positively correlate with the availability of specific nutrients owing to corresponding changes in flux through the HBP. However, in recent years, it has become increasingly clear that metabolic regulation of O-GlcNAc signalling is far more complex than we originally thought.
Nutritional regulation of O-GlcNAc signalling.
Early biochemical analysis of OGT demonstrated that increasing the concentration of UDP-GlcNAc enhances in vitro O-GlcNAcylation of various peptide substrates in a dose-dependent manner 87 . As biosynthesis of UDP-GlcNAc via the HBP requires glucose, glutamine, acetyl-CoA and UTP (FIG. 1a) , cellular O-GlcNAcylation levels are thought to be elevated when the availability of these nutrients is increased. To date, numerous groups have observed this trend, particularly in response to modulation of extracellular glucose concentrations in vitro 84 . Hyperglycaemia has been shown to raise cellular O-GlcNAcylation levels in various tissues in vivo 88 . Many studies have also demonstrated that even low concentrations of glucosamine, a metabolite that bypasses the rate-limiting step of the HBP (the conversion of fructose-6-phosphate to glucosamine-6-phosphate by glutamine-fructose-6-phosphate amido transferase 1 (GFAT1; also known as GFPT1)) (FIG. 1a) , can dramatically enhance O-GlcNAcylation, further supporting the notion that HBP flux is a major determinant of cellular O-GlcNAcylation levels 84, 85 . However, accumulating evidence indicates that the relationship between nutrient availability and O-GlcNAcylation is not a simple pos itive correlation, which suggests that changes in HBP flux are not the only factor driving the nutrient sensitivity of this modification. For example, O-GlcNAcylation of PGC1α was shown to peak at 5 mM glucose and decrease gradually as glucose concentrations approached either hypo-or hyperglycaemia 26 . As UDP-GlcNAc levels would be highest under hyperglycaemic conditions, this pattern of O-GlcNAcylation would be unexpected in the conventional view that O-GlcNAcylation levels respond linearly to changes in nutrient availability. Consistent with these observations,
Lipid rafts
Cholesterol-and sphingolipidenriched microdomains in the plasma membrane, which serve as organizing centres for signal transduction.
Ketogenesis
The production of ketone bodies (acetoacetate, acetone and β-hydroxybutyrate) from the catabolism of fatty acids and some amino acids; ketone bodies become a major energy source for various organs during fasting and for the brain during long-term starvation.
glucose production and gluco neogenic gene expression, which are regulated by O-GlcNAcylation of PGC1α, were also shown to peak at 5 mM glucose and to be gradually suppressed as glucose availability is increased or decreased 26 . This suggests that O-GlcNAcylation levels vary on a substrate-by-substrate basis depending on the overall metabolic needs of the cell and are not simply a direct readout of HBP flux.
How are O-GlcNAcylation levels regulated in both a nutrient-sensitive and a substrate-specific manner? In the case of PGC1α, the interaction between OGT and its adaptor protein HCF1 displayed the same response to changes in glucose concentration as that observed for O-GlcNAcylation of PGC1α 26 . This suggests that nutrient availability can also regulate substrate O-GlcNAcylation levels by modulating the interactions between OGT and its adaptor proteins (see discussion in Adaptor protein hypothesis).
Another unexpected phenomenon that has been consistently observed in numerous studies is a dramatic global increase in cellular O-GlcNAcylation levels in conditions of nutrient deprivation 25, 84, 85, 89 . As UDPGlcNAc levels are decreased under these conditions, this effect cannot be explained by changes in HBP flux 84, 85 . One potential mechanism that could mediate this response is an upregulation of OGT expression, which may raise cellular O-GlcNAcylation levels despite the reduced intracellular availability of UDP-GlcNAc 25, 84, 85 . Furthermore, an accumulation of unfolded proteins due to nutrient stress may increase the abundance of high affinity substrates for OGT, which would enhance the efficiency of protein O-GlcNAcylation on a global scale (see discussion in Nonspecific O-GlcNAcylation hypothesis). Thus, we propose that nutrient availability regulates cellular O-GlcNAcylation levels not only by determining the abundance of UDP-GlcNAc but also by modulating the levels of OGT, OGA and their respective adaptor proteins and substrates (FIG. 4a) .
Hormonal regulation of O-GlcNAc signalling. Our current understanding of metabolic regulation of O-GlcNAc signalling is derived primarily from in vitro experiments in which the availability of various nutrients can be dramatically altered by modulating their concentrations in cell culture medium. However, in vivo nutrient availability is unlikely to undergo such drastic changes in normal physiological conditions; thus, nutritional regulation of O-GlcNAc signalling may function primarily to fine-tune cellular O-GlcNAcylation levels in response to local metabolic cues. As a key regulator of cellular pathways that control whole-body metabolism, O-GlcNAcylation is also sensitive to systemic metabolic changes, which are communicated to the relevant cell types and tissues by hormonal signals. Indeed, several studies have now shown that O-GlcNAc signalling is regulated by a number of hormones that encode information about systemic metabolic status, which include insulin, glucagon and ghrelin.
As disruption of O-GlcNAc homeostasis has been implicated in the pathogenesis of insulin resistance, the effect of insulin stimulation on O-GlcNAc signalling has been particularly well studied 5 . Specifically, insulin signalling has been shown to regulate OGT through several distinct mechanisms, which include modulation of OGT expression, subcellular localization and enzymatic activity. In addition to upregulating OGT expression through a PI3K-dependent pathway, insulin stimulation promotes the translocation of OGT from the nucleus to the cytoplasm and the localization of OGT to lipid rafts in the plasma membrane, where it is activated by tyrosine phosphorylation by the insulin receptor 5, 90, 91 (FIG. 3c) .
Modulation of O-GlcNAc signalling in response to insulin stimulation enables temporal control of insulin signal transduction and its downstream effects on cellular metabolism (see discussion in Temporal regulation of cell signalling dynamics).
Recent studies have revealed that other hormones can also regulate O-GlcNAc signalling in response to systemic changes in metabolic status. For example, starvationinduced glucagon signalling in the liver stimulates phosphorylation of OGT by calcium/calmodulin-dependent kinase II (CaMKII), which targets OGT to the autophagy-initiating kinase UNC-51-like kinase 1 (ULK1) and thereby activates autophagy. Liver autophagy then generates amino acids and fatty acids as substrates for gluconeogenesis and ketogenesis, which are crit ical pathways in the metabolic response to starvation (X.Y. and K.Q., unpublished observations). Ghrelin -secreted by the empty stomach during fasting -raises cellular O-GlcNAcylation levels in the appetite-stimulating agouti-related protein (AgRP) neurons, which increases 
Browning of white adipose tissue
The increased white adipose tissue expression of uncoupling protein 1 (UCP1), which is typically found in the mitochondria of brown adipose tissue; UCP1 uncouples the electron transport chain from ATP production to generate heat.
their firing rate through activation of potassium voltagegated channel subfamily Q member 3 (KCNQ3). Increased firing of AgRP neurons during fasting reduces energy expenditure by suppressing browning of white adipose tissue (WAT) 92 . Thus, modulation of O-GlcNAc signalling in specific cell types and tissues (liver and AgRP neurons) by hormones (insulin, glucagon and ghrelin) secreted in response to systemic metabolic changes (feeding, starvation and fasting) leads to the regulation of key response pathways (insulin signalling, autophagy and WAT browning) that help to maintain metabolic homeostasis (FIG. 4b) .
Maintenance of O-GlcNAc homeostasis
As O-GlcNAcylation plays a vital role in spatiotemporal regulation of cellular processes in response to nutritional and hormonal cues, maintenance of O-GlcNAc homeostasis is essential for optimal cellular function. Indeed, disruption of O-GlcNAc homeostasis has been implicated in the pathogenesis of a multitude of human diseases [3] [4] [5] [6] [7] [8] [9] . For example, a single nucleotide polymorphism in the gene that encodes human OGA, MGEA5, has been shown to be associated with an increased risk of developing type 2 diabetes mellitus in the Mexican-American population 93 . Consistent with this finding, knockout of the Caenorhabditis elegans OGA gene oga-1 reduces lipid storage, a metabolic perturbation that is associated with insulin resistance in humans 94 . Interestingly, the C. elegans ogt-1 knockout animals have a similar phenotype to oga-1 knockout animals, despite the fact that these knockouts have opposite effects on global O-GlcNAcylation levels 94, 95 . This intriguing observation points to the existence of an 'optimal zone' within which global O-GlcNAcylation levels must remain in order to preserve normal cellular function (FIG. 5) .
How might cells be able to maintain global O-GlcNAcylation levels within the optimal zone and under what conditions might these mechanisms become deregulated? We hypothesize that cellular O-GlcNAc homeostasis is maintained through mutual regulation of OGT and OGA at the transcriptional and posttranslational levels. In particular, OGT may regulate the transcription of MGEA5 as well as the enzymatic activity and stability of OGA and vice versa. Mutual regulation in this manner would allow cells to maintain a balance between OGT and OGA expression and activity, thereby generating a 'buffering' system that enables precise control of global O-GlcNAcylation levels (FIG. 5) . Indeed, OGA has been shown to upregulate OGT expression through activation of the transcription factor CCAAT/enhancerbinding protein-β (CEBPβ) 96 . Conversely, pharmacological inhibition of OGA has been shown to increase the expression of MGEA5, which indicates that elevated cellular O-GlcNAcylation levels promote compensatory transcription of MGEA5, perhaps through enhanced O-GlcNAcylation of specific transcription factors and cofactors 97 . Both OGT and OGA are also known to be O-GlcNAcylated, which suggests that they are subject to autoregulation and mutual regulation at the posttranslational level 51, 98 . We suspect that O-GlcNAcylation of OGT and OGA modulates their activities and stabilities; however, the exact functions of the identified modification sites have yet to be determined.
As with any buffering system, the cellular O-GlcNAcylation 'buffer' that is generated by the mutual regu lation of OGT and OGA can probably tolerate moderate and acute perturbations but may be overcome by severe and chronic insults. As O-GlcNAcylation is a nutrient sensor, physiological variations in nutrient availability will produce mild fluctuations in cellular O-GlcNAcylation levels within the limits of the 'optimal zone'; however, prolonged nutrient deficiency or excess may drive cellular O-GlcNAcylation levels beyond the 'optimal zone' , resulting in a gradual loss of normal cellu lar function. Similarly, as O-GlcNAcylation is protective against cellular stress, global O-GlcNAcylation levels will be transiently elevated in response to moderate stress stimuli; however, sustained elevation of global O-GlcNAcylation levels beyond the 'optimal zone' due to severe and chronic stress may have deleterious effects on overall cellular function despite being protective against the specific cellular insult. We propose that a loss of O-GlcNAc homeostasis due to disruption of the cellular O-GlcNAcylation 'buffer' that is generated by the mutual regulation of OGT and OGA is an important factor that contributes to the pathogenesis of various human diseases (FIG. 5) .
Conclusions and perspectives
Since O-GlcNAcylation of intracellular proteins was first described by Torres and Hart in 1984, significant strides have been made in identifying 'what' proteins and pathways are regulated by this modification 99 . In this Review, we focused our discussion on key concepts and hypotheses that are derived from this extensive body of knowledge: 'how' OGT and OGA recognize their numerous substrates; 'when' and 'where' O-GlcNAc signalling regulates the vital processes of the cell; 'how' nutrients and hormones control cellular O-GlcNAcylation levels; and 'how' O-GlcNAc homeostasis is maintained in order to achieve optimal cellular function. It is our hope that this framework of ideas -some well-established and others more speculative -will guide continued investigation into the 'what' , 'when' , 'where' and 'how' of this thriving field. Ultimately, however, the question we as a field would like to answer is: 'why?' Specifically, 'why' did the O-GlcNAcylation system first arise and 'why' has it been evolutionarily conserved from C. elegans and Drosophila melanogaster to mice and humans? One perspective from which to address this question is to consider which cellular and physiological functions of O-GlcNAcylation are shared across species. Although we have generally focused on studies performed in mammal ian systems in this Review, valuable insights have also been gained from significant efforts to character ize the role of O-GlcNAcylation in other model organisms, which include C. elegans, D. melanogaster and Arabidopsis thaliana 52, 72, [100] [101] [102] [103] [104] . Like those in mammalian systems, studies in these organisms have demonstrated the importance of O-GlcNAc signalling in the regulation of diverse cellular processes such as autophagy 105, 106 , the circadian clock [107] [108] [109] , epigenetics 72, 100, 110 , carbohydrate and lipid metabolism 94, 95 , hormone signalling 109, 111 , protein homeostasis 112, 113 and the stress response 114, 115 . Thus, it is likely that the need for a robust biological system to regulate these vital cellular pathways in a coordinated and integrated fashion has contributed to the evolutionary conservation of O-GlcNAcylation.
Another perspective from which to address this question is to consider what unique and indispensable molecular role is fulfilled by O-GlcNAcylation. We propose that O-GlcNAcylation can be viewed as the essential 'grease and glue' of the cell: it acts as a 'grease' by coating target proteins (folded or unfolded, mature or nascent) and preventing unwanted protein aggregation or modification (see discussion in Nonspecific O-GlcNAcylation hypothesis); it also acts as a 'glue' by modulating protein-protein interactions in time and space in response to internal and external cues, thereby affecting the functions of various proteins in the cell (see discussion in Functions of O-GlcNAcylation).
Although both of these perspectives yield intriguing hypotheses, our knowledge of the 'origin story' of O-GlcNA cylation is, ultimately, far from complete. Moving forward, systems biology approaches that enable us to observe how O-GlcNAc signalling coordinates and integrates the diverse molecular networks of the cell will become increasingly important as we seek to understand the 'why' of this fascinating modification.
